These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 34380744)
1. N-Glycosylation Patterns Correlate with Hepatocellular Carcinoma Genetic Subtypes. DelaCourt A; Black A; Angel P; Drake R; Hoshida Y; Singal A; Lewin D; Taouli B; Lewis S; Schwarz M; Fiel MI; Mehta AS Mol Cancer Res; 2021 Nov; 19(11):1868-1877. PubMed ID: 34380744 [TBL] [Abstract][Full Text] [Related]
2. Glycoproteomic markers of hepatocellular carcinoma-mass spectrometry based approaches. Zhu J; Warner E; Parikh ND; Lubman DM Mass Spectrom Rev; 2019 May; 38(3):265-290. PubMed ID: 30472795 [TBL] [Abstract][Full Text] [Related]
3. Mass Spectrometric N-Glycan Analysis of Haptoglobin from Patient Serum Samples Using a 96-Well Plate Format. Zhu J; Wu J; Yin H; Marrero J; Lubman DM J Proteome Res; 2015 Nov; 14(11):4932-9. PubMed ID: 26448449 [TBL] [Abstract][Full Text] [Related]
4. MALDI imaging-based classification of hepatocellular carcinoma and non-malignant lesions in fibrotic liver tissue. Marquardt C; Tolstik T; Bielecki C; Kaufmann R; Crecelius AC; Schubert US; Settmacher U; Stallmach A; Dirsch O Z Gastroenterol; 2015 Jan; 53(1):33-9. PubMed ID: 25594705 [TBL] [Abstract][Full Text] [Related]
5. MRI features of histologic subtypes of hepatocellular carcinoma: correlation with histologic, genetic, and molecular biologic classification. Yoon JK; Choi JY; Rhee H; Park YN Eur Radiol; 2022 Aug; 32(8):5119-5133. PubMed ID: 35258675 [TBL] [Abstract][Full Text] [Related]
6. A pilot study of salivary N-glycome in HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Qin Y; Zhong Y; Ma T; Zhang J; Yang G; Guan F; Li Z; Li B Glycoconj J; 2017 Aug; 34(4):523-535. PubMed ID: 28389847 [TBL] [Abstract][Full Text] [Related]
7. N-Linked Glycan Branching and Fucosylation Are Increased Directly in Hcc Tissue As Determined through in Situ Glycan Imaging. West CA; Wang M; Herrera H; Liang H; Black A; Angel PM; Drake RR; Mehta AS J Proteome Res; 2018 Oct; 17(10):3454-3462. PubMed ID: 30110170 [TBL] [Abstract][Full Text] [Related]
8. Two-Dimensional N-Glycan Distribution Mapping of Hepatocellular Carcinoma Tissues by MALDI-Imaging Mass Spectrometry. Powers TW; Holst S; Wuhrer M; Mehta AS; Drake RR Biomolecules; 2015 Oct; 5(4):2554-72. PubMed ID: 26501333 [TBL] [Abstract][Full Text] [Related]
9. An update on subtypes of hepatocellular carcinoma: From morphology to molecular. Vyas M; Jain D Indian J Pathol Microbiol; 2021 Jun; 64(Supplement):S112-S120. PubMed ID: 34135152 [TBL] [Abstract][Full Text] [Related]
10. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas. Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893 [TBL] [Abstract][Full Text] [Related]
11. Nondestructive molecular imaging by Raman spectroscopy vs. marker detection by MALDI IMS for an early diagnosis of HCC. Kirchberger-Tolstik T; Ryabchykov O; Bocklitz T; Dirsch O; Settmacher U; Popp J; Stallmach A Analyst; 2021 Feb; 146(4):1239-1252. PubMed ID: 33313629 [TBL] [Abstract][Full Text] [Related]
12. MALDI imaging mass spectrometry profiling of N-glycans in formalin-fixed paraffin embedded clinical tissue blocks and tissue microarrays. Powers TW; Neely BA; Shao Y; Tang H; Troyer DA; Mehta AS; Haab BB; Drake RR PLoS One; 2014; 9(9):e106255. PubMed ID: 25184632 [TBL] [Abstract][Full Text] [Related]
13. Glycosylation-related molecular subtypes and risk score of hepatocellular carcinoma: Novel insights to clinical decision-making. Shi Y; Wang Y; Yang R; Zhang W; Zhang Y; Feng K; Lv Q; Niu K; Chen J; Li L; Zhang Y Front Endocrinol (Lausanne); 2022; 13():1090324. PubMed ID: 36605944 [TBL] [Abstract][Full Text] [Related]
14. Identification of abnormal fucosylated-glycans recognized by LTL in saliva of HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Zhang J; Zhong Y; Zhang P; Du H; Shu J; Liu X; Zhang H; Guo Y; Jia Z; Niu L; Yang F; Li Z Glycobiology; 2019 Mar; 29(3):242-259. PubMed ID: 30535277 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive molecular and immunological characterization of hepatocellular carcinoma. Shimada S; Mogushi K; Akiyama Y; Furuyama T; Watanabe S; Ogura T; Ogawa K; Ono H; Mitsunori Y; Ban D; Kudo A; Arii S; Tanabe M; Wands JR; Tanaka S EBioMedicine; 2019 Feb; 40():457-470. PubMed ID: 30598371 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs. Cheng L; Gao S; Song X; Dong W; Zhou H; Zhao L; Jia L Oncotarget; 2016 Sep; 7(38):61199-61214. PubMed ID: 27533464 [TBL] [Abstract][Full Text] [Related]
17. Insights into glycan biosynthesis in chemically-induced hepatocellular carcinoma in rats: A glycomic analysis. Amin A; Bashir A; Zaki N; McCarthy D; Ahmed S; Lotfy M World J Gastroenterol; 2015 May; 21(20):6167-79. PubMed ID: 26034352 [TBL] [Abstract][Full Text] [Related]
18. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Villanueva A; Hoshida Y; Battiston C; Tovar V; Sia D; Alsinet C; Cornella H; Liberzon A; Kobayashi M; Kumada H; Thung SN; Bruix J; Newell P; April C; Fan JB; Roayaie S; Mazzaferro V; Schwartz ME; Llovet JM Gastroenterology; 2011 May; 140(5):1501-12.e2. PubMed ID: 21320499 [TBL] [Abstract][Full Text] [Related]
19. The Spatial Extracellular Proteomic Tumor Microenvironment Distinguishes Molecular Subtypes of Hepatocellular Carcinoma. Macdonald JK; Taylor HB; Wang M; Delacourt A; Edge C; Lewin DN; Kubota N; Fujiwara N; Rasha F; Marquez CA; Ono A; Oka S; Chayama K; Lewis S; Taouli B; Schwartz M; Fiel MI; Drake RR; Hoshida Y; Mehta AS; Angel PM J Proteome Res; 2024 Sep; 23(9):3791-3805. PubMed ID: 38980715 [TBL] [Abstract][Full Text] [Related]
20. Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents. Gao Q; Wang ZC; Duan M; Lin YH; Zhou XY; Worthley DL; Wang XY; Niu G; Xia Y; Deng M; Liu LZ; Shi JY; Yang LX; Zhang S; Ding ZB; Zhou J; Liang CM; Cao Y; Xiong L; Xi R; Shi YY; Fan J Gastroenterology; 2017 Jan; 152(1):232-242.e4. PubMed ID: 27639803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]